Effect of the Thrive AI Health App on Lifestyle Behaviors and Quality of Life
Yale University · with Thrive AI Health · NCT07376655
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 40+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 20
- US sites recruiting
- 1
- Study start
- June 4, 2026
- Record last updated
- June 17, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goals of this randomized trial is to learn:
- If the Thrive AI Health app will help adults improve their everyday habits (diet, exercise, and sleep).
- How often participants will use the Thrive AI Health app to which they will have free access
The Thrive AI Health app uses artificial intelligence (AI) to give personalized advice. It is designed to help people eat better, exercise more, manage stress, and sleep well.
Researchers will compare changes in diet, exercise and sleep in participants using the app to those participants not using the app.
Participants will complete study questionnaires and an in-person visit at the beginning and end of the study.
Being studied: App
Conditions: Diabetes Type 2; Overweight or Obesity
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Be at high risk for chronic disease defined as:
Body mass index (BMI)>25
BMI\<=25 who are prediabetic or have type 2 diabetes
- Aged 40 years or older
Exclusion Criteria
- Unable to walk
Recruiting US locations
Yale University
New Haven, CT 06520
Study contacts (from the official record)
- Melinda Irwin · 203-785-6392 · melinda.irwin@yale.edu
Similar studies in Connecticut
All weight loss studies in Connecticut →- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- Waterbury, CT + 55 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingPhase 3
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Hoffmann-La Roche
- Location
- New Haven, CT + 43 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
Regeneron Pharmaceuticals
- Location
- Waterbury, CT + 20 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Eli Lilly and Company
- Location
- Bridgeport, CT + 59 other US sites
- Eligibility basics
- Ages 18+